Merck seeks EMA to authorize Covid-19 pill Molnupiravir Hina Zahid25 Nov 2021 10:00 AM ISTNew Delhi: The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to...
Covaxin 50 percent effective against symptomatic Covid-19: Lancet study Medical Dialogues Bureau25 Nov 2021 9:15 AM ISTThe latest study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from April 15May 15, who were...
WHO to set guidelines on COVID antiviral pills soon Ruchika Sharma14 Nov 2021 9:00 AM ISTGeneva: World Health Organization (WHO) officials said on Friday they were hoping to convene a meeting soon to set guidelines on the use of COVID-19...
Shortage of 2 billion syringes in 2022, warns WHO Ruchika Sharma11 Nov 2021 11:00 AM ISTGeneva: The World Health Organization (WHO) warned Tuesday there could be shortfall of up to two billion syringes in 2022, which threatens to hamper...
Novavax files for COVID vaccine EUL with WHO Ruchika Sharma8 Nov 2021 12:42 PM ISTGaithersburg: Novavax, Inc. has recently announced the completion of its rolling submission to the World Health Organization (WHO) for emergency use...
Health Bulletin 2/ November/2021 Roshni Dhar8 Nov 2021 11:51 AM ISTHere are Top Health Stories of the dayHelp Expedite NEET PG Counselling: Doctors tell Chief Justice of IndiaPointing towards the unusual delay in the...
Proud Moment for India: Bharat Biotech Covaxin gets WHO approval for emergency use listing Farhat Nasim6 Nov 2021 3:09 PM ISTBesides demonstrating 77.8 per cent effectiveness against symptomatic COVID, Covaxin has shown 65.2 per cent protection against the new Delta variant.
Union Health Minister congratulates ICMR, scientists over WHO nod to Covaxin MD Editorial Team6 Nov 2021 9:30 AM ISTThe Union Health Minister said, Covaxin, which is regulated and modified in India, has been approved by WHO today. I congratulate scientists of the...
Bharat Biotech gets CDSCO nod for shelf-life extension of Covaxin Hina Zahid5 Nov 2021 3:39 PM ISTBengaluru: Bharat Biotech's COVID-19 vaccine has been granted an extension of shelf life for up to 12 months from the date of manufacture by India's...
Heparin dose sufficient to prevent COVID-19 deaths four times higher than WHO recommended dose Dr. Kamal Kant Kohli2 Nov 2021 9:00 AM ISTThe anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of...
India can supply 5 billion Covaxin dosages to world post WHO nod: PM Modi MD Bureau1 Nov 2021 1:10 PM ISTNew Delhi: Terming it as Indias contribution to reduce vaccine inequity, Prime Minister Narendra Modi said if the WHO approved Covaxin, Indias...
Covishield re-vaccination after Covaxin: SC saids to wait for WHO decision MD Bureau31 Oct 2021 11:00 AM ISTNew Delhi: The Supreme Court on Friday said it will wait for the WHO's decision on indigenous vaccine Covaxin's recognition, before taking up a...
